About the Philippines
- Overview
- Philippine Pharmaceutical Industry
|
|
| |
Home » About the Philippines » Philippine Pharmaceutical Industry
Philippine Pharmaceutical Industry
The Philippine pharmaceutical market has total value of approximately US$2.5b (2007) with similar growth of 9% for the past three years. MNC's value shares remain stable, however, national companies are significantly climbing up the ranks. Causes of mortality and morbidity remains the same; trending is reflected in top therapeutic categories.
- The US$2.5 billion (2007) Philippine pharmaceutical market is growing at around 9% annually.
- Top causes of mortality and morbidity continue to be respiratory and cardiovascular diseases, which is reflected in strong demand for drugs in these categories.
- About 80% of the products are sold through drugstores, about 10% through the hospitals and another 10% through government institutions, dispensing physicians (2007 data)
- Branded products account for 97% of drugs sold and generic products for 3% (2007 data)
- Multinational companies account for approximately 65% with national companies meeting 35% of the demand.
For more comprehensive information on Philippine Pharmaceutical Industry and Health demographics, click here.
|
|
